Related Experiment Video
Updated: May 26, 2026

10:05
High-throughput Detection Method for Influenza Virus
Published on: February 4, 2012
A quantitative comet infection assay for influenza virus
Stephen M Lindsay1, Andrea Timm, John Yin
1Department of Chemical and Biological Engineering, Systems Biology Theme, Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison, WI 53715, USA. smlindsay@wisc.edu
Journal of Virological Methods
|December 14, 2011
Summary
The virus comet assay offers greater sensitivity for detecting antiviral drug effectiveness against influenza viruses compared to traditional methods. This enhanced assay requires less drug, reducing costs and improving screening accuracy.
Area of Science:
- Virology
- Biotechnology
- Drug Discovery
Background:
- The virus comet assay is a cell-based method for evaluating antiviral drugs or antibodies.
- It differs from plaque assays by utilizing spontaneous fluid flow for virus spread.
- Quantitative comet assays demonstrate significantly higher sensitivity to antivirals than plaque assays.
Purpose of the Study:
- To demonstrate a quantitative virus comet assay for influenza virus.
- To assess the assay's sensitivity to the antiviral drug ribavirin.
- To evaluate AX4 cells as a host cell line for improved assay performance.
Main Methods:
- Development and implementation of a quantitative virus comet assay for influenza.
- Utilizing AX4 cells (MDCK cells with enhanced α2-6 sialic acid) as the host cell line.
- Comparison of antiviral sensitivity with traditional plaque assays.
Main Results:
- The quantitative comet assay showed a 13-fold increase in sensitivity to ribavirin for influenza virus.
- AX4 cells reduced comet size variability, offering improved assay consistency.
- The assay also provided insights into fluid dynamics and evaporation effects in microplates.
Conclusions:
- The quantitative virus comet assay is a highly sensitive method for evaluating influenza antivirals.
- Enhanced host cells like AX4 improve assay reliability and reduce variability.
- This assay format offers potential for reduced drug usage, lower costs, and more accurate drug screening.

